Evidence map›Paper›PMID 9637792›Full record

ReviewEnvironmental health perspectives1998

The Environmental Genome Project: functional analysis of polymorphisms.

F P Guengerich

Open access · diamondAbstract readReview
In one paragraph

Review in Environmental health perspectives, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Gene-environment interactions in the development of complex disease phenotypes.International journal of environmental research and public health · 2008
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Application of genomics to toxicology research.Environmental health perspectives · 2002
    Review
  14. Review
  15. A bold new direction for environmental health research.American journal of public health · 2001
    Article
  16. Toxicogenomics: "the call of the wild chip".Environmental health perspectives · 2001
    Article
  17. Review
  18. Pharmacogenomics. Interview by Clare Thompson.BMJ (Clinical research ed.) · 1999
    Article
  19. Pharmacogenomics.The Western journal of medicine · 1999
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

F P GuengerichDepartment of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, USA.
Vanderbilt University · US

Funding

Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
ENZYMIC ACTIVATION OF CHEMICAL CARCINOGENSR35CA044353 · NCI · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1987 to 2000
$974k
NCI NIH HHS R35 CA44353NIEHS NIH HHS P30 ES00267
6 · The paper itself

Abstract

The ultimate goal of the Environmental Genome Project is the improvement of human health on the basis of information about the variations in certain genes. The first phase of the project will involve the selection of the human genes and characterization of the alleles occurring in the American population. However, intelligent use of this information will require analysis of the relevance of the allelic differences. Epidemiology alone will not solve the problem, and mechanistic studies will be required. Factors to be considered in the design of functional analyses are considered in this commentary.

Indexed as

GenomeEnvironmental PollutantsGenetic Diseases, InbornHumansMutagensNational Institutes of Health (U.S.)United StatesEnvironmental PollutantsMutagens

Identifiers

PMID9637792
PMCPMC1533131
OpenAlexW1993902331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.